Thinking outside the box: New strategies for antichlamydial control

Future Microbiology

Volumn 7, Issue 4, 2012, Pages 427-429

  Valdivia, Raphael H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

anti infective; Chlamydia; therapy; virulence

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ANTIMICROBIAL THERAPY; BACTERIAL GENETICS; BACTERIAL VIRULENCE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE TRANSMISSION; EDITORIAL; HEALTH CARE COST; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; SINGLE DRUG DOSE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHLAMYDIA; CHLAMYDIA INFECTIONS; HUMANS;

CHLAMYDIA;

EID: 84858972583     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.25     Document Type: Editorial

References (20)

1. Gottlieb SL, Brunham RC, Byrne GI, Martin DH, Xu F, Berman SM. Introduction: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J. Infect. Dis. 201(Suppl. 2), S85-S87 (2010)
2. Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC. Summary: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J. Infect. Dis. 201(Suppl. 2), S190-5204 (2010)
3. Rekart ML, Brunham RC. Epidemiology of chlamydial infection: are we losing groun? Sex. Transm. Infect. 84, 87-91 (2008)
4. Brunham RC, Rekart ML The arrested immunity hypothesis and the epidemiology of chlamydia control Sex. Transm. Infect. 35, 53-54 (2008).
5. Rank RG. Chlamydia. In: Vaccines for Biodefense and Emerging and Neglected Diseases. Barrett AD, Stanberry LR (Eds). Elsevier, The Netherlands, 835-858 (2008)
6. Yu H, Karunakaran KP, Kelly I et al. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J. Immunol. 186, 3615-3621 (2011).
7. Kari L, Whitmire WM, Olivares-Zavaleta N et al. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J. Exp. Med. 208, 2217-2223 (2011).
8. O'Connell CM, Ingalls RR, Andrews CW Jr, Scurlock AM, Darville T. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 179, 4027-4034 (2007).
9. Carlson JH, Whitmire WM, Crane DD et al. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect. Immun. 76, 2273-2283 (2008).
10. Miyairi I, Laxton JD, Wang X et al. Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity. J Infect. Dis. 204, 654-663 (2011).
11. Frazer LC, Darville T, Chandra-Kuntal K et al. Plasmid-cured chlamydia caviae activates TLR2-dependent signaling and retains virulence in the guinea pig model of genital tract infection. PloS ONE 7, E30747 (2012).
12. Zhong C. Chlamydia trachomatis secretion of proteases for manipulating host signaling pathways. Front. Microbiol. 2, 14 (2011).
13. Cocchiaro JL, Valdivia RH. New insights into Chlamydia intracellular survival mechanisms. Cell. Microbiob. 11, 1571-1578 (2009).
14. Betts HJ, Wolf K, Fields KA. Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal. Curr. Opin. Microbiol. 12, 81-87 (2009).
15. Wang Y, Kahane S, Cutcliffe LT et al. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 7, E1002258 (2011).
16. Kari L, Goheen MM, Randall LB et al. Generation of targeted Chlamydia trachomatis null mutants. Proc. Natl Acad. Sci. USA 108, 7189-7193 (2011).
17. Nguyen BD, Valdivia RH. Virulence determinants in the obligate in tracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches. Proc. Natl Acad. Sci. USA 109(4), 1263-1268 (2012).
18. Barczak AK, Hung DT. Productive steps toward an antimicrobial targeting virulence. Curr. Opin. Microbiol, 12, 490-496 (2009).
19. Nguyen BD, Cunningham D, Liang X et al. Lipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis. Proc. Natl Acad. Sci. USA 108, 10284-10289 (2011).
20. Jorgensen I, Bednar MM, Amin V et al. The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence. Cell Host Microbe 10, 21-32 (2011).